GSK, EvoGenix begin second project on antibodies

08/16/2007 | Age (Melbourne, Australia), The

Australian biotech EvoGenix Ltd. said it has begun the second of three proposed projects with U.K.-based GlaxoSmithKline involving technologies used to develop antibodies for the market. The latest collaboration will attempt to "improve the properties of either an antibody or a protein to ... increase the effectiveness of drugs," EvoGenix CEO Dr. Merilyn Sleigh said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC